Skip to content

Treatment of Alopecia Areata

A randomized clinical trial evaluating the efficacy and safety of Jesners solution against 88% Phenol: In the treatment of Alopecia Areata. - Nil

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062980
Enrollment
92
Registered
2024-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L638- Other alopecia areata

Interventions

Intervention1: Jessner’s solution (salicyclic acid+ lactic acid+ Resorcinol 14% each) provided in containers according to the manufactures: 1.The patch to be treated will be wiped with alcohol and ace

Sponsors

Dr Rakesh Tilak raj
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.who has not received any treatment during previous 2 months before commencing of the study. 2.Patients with minimum of two patches; ranging in circumference between 3cm to 10 cm. 3.Patients with patchy patches of stable AA over the scalp 4.Patients willing to be part of the study after informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients treated with any other topical agent or immunosuppressive drugs. 2.Patients with scarring alopecia and scalp condition affecting the outcomes. 3.Patients who were on any allopathic or homeopathic treatment. 4.Patients with psychiatric medications and unrealistic expectations. 5.Pregnant and lactating mothers. 6.Patients with a history of keloid and hypertrophic scars. 7.Patient with any systemic disease (Cardiac, Renal, Hepatic, HIV, etc). 8.Patient with history of drug abuse. 9.Patient with collagen vascular disorder and auto-immune. 10.Patients with alopecia totalis and universalis. 11.Unwilling patients. 12.Other causes of alopecia like Androgenic alopecia, Diffuse telogen effluvium

Design outcomes

Primary

MeasureTime frame
1.To assess the safety and therapeutic efficacy of 12 weeks regimen of administration of investigational products in adult Alopecia areata 2.Treatment frequencyTimepoint: Baseline,4 weeks,8weeks and 12weeks

Secondary

MeasureTime frame
1. Assessment of hair growth from baseline using digital photography and Dermoscopy or Trichoscopy. 2.Time for regrowth 3.Sustainability of hair growth response over a 12 weeks post treatment period of observation. 4. Hair regrowth outcome assessment using SALT scoring.Timepoint: Post treatment observation follow up at 1. 16 weeks 2. 20 weeks 3. 24 weeks.

Countries

India

Contacts

Public ContactDr Sahib Preet kaur

Government Medical college

tejinderkaur@gmail.com9815514499

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026